NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Health Care, Technological Change, and Altruistic Consumption Externalities

Tomas Philipson, Stephane Mechoulan, Anupam Jena

NBER Working Paper No. 11930
Issued in January 2006
NBER Program(s):   HC   PE

Traditional economic analysis has proposed well known remedies to deal with consumption externalities and inefficient technological change in isolation, but lacks a general framework for addressing them jointly. We argue that the joint determination of R&D and consumption externalities is central to health care industries around the world generally, and for the pharmaceutical industry in particular. This is because technological change drives the expansion of the health care sector and altruism seems to motivate many public subsidies such as Medicaid in the US. We stress that standard remedies to the two problems in isolation are inefficient — Pigouvian corrections to consumption externalities are inefficient under technological change and standard R&D stimuli are inefficient because they focus only on consumer and producer surplus, not the altruistic surplus accruing to non-consumers. We provide illustrative calculations of the dynamic inefficiency in the level of US R&D spending due to the inability of innovators to appropriate the altruistic surplus. We find that altruistic gains amount to about a quarter of consumer surplus in the baseline scenario. Our analysis implies that total R&D could be under-provided by as much as 60 percent.

download in pdf format
   (178 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (178 K) or via email.

This paper was revised on April 20, 2009

Acknowledgments

Machine-readable bibliographic record - MARC, RIS, BibTeX

Published: Journal of Law and Economics Vol. 53, No. 3. The University of Chicago Press. August 2010

This paper is a revision of the earlier NBER working paper w9598, Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets, Tomas Philipson, Stephane Mechoulan
Users who downloaded this paper also downloaded these:
Glied w13885 Universal Public Health Insurance and Private Coverage: Externalities in Health Care Consumption
Philipson and Mechoulan w9598 Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
 
Publications
Activities
Meetings
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us